MediciNova
MNOV | NASDAQ
$1.34
-$0.05 (-3.94%)
At close: Nov 16, 2026, 4:00 PM ET
$1.33
-$0.01 (-0.60%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-3.94%
(1D)No price chart data available for 1D timeframe.
Rating
48.5
+2.0 ptsFundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #321/1021 (Top 31%)
Key Statistics
Market Data
Market Cap $68.65M
1D Range
1.34 1.41
52W Range
1.23 3.45
Valuation (TTM)
PE -6.09
PB 1.67
EV/EBITDA -3.72
Valuation (NTM)
Forward PE N/A
Forward PEG 0.20
Price Target $6.00
Cash Flow
FCF Yield -14.3%
SBC Adj. FCF Yield -16.3%
SBC Impact -13.8%
Margins
Gross Margin 46.8%
Operating Margin -1232.2%
FCF Margin -1047.4%
Growth (CAGR)
Revenue 3Y | 5Y -2.2% |
-25.4%
Dil EPS 3Y | 5Y -2.2% |
1.3%
FCF 3Y | 5Y -3.1% |
6.4%
Returns
ROA -23.3%
ROE -26.5%
ROIC -27.5%
Financial Health
Net Cash
$29.26M
Current Ratio 8.75
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
MediciNova, Inc. is a biopharmaceutical firm dedicated to discovering and advancing innovative small molecule therapies for severe illnesses where current treatments are insufficient within the United...
Sector Healthcare
Industry Biotechnology
Employees 6
IPO Date Dec 8, 2006
Website www.medicinova.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 12, 2026
EPS
-$0.06
Beat +4.00%
YoY:
0.00% REV
$138.56K
Beat +177.11%
YoY:
+125.29%Next Earnings
Feb 19, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
1
Consensus
Buy
Price Target
$6.00
Upside
+347.76%
Buy (1)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove MNOV